Prescription Drug Abuse - Susan Awad

Post on 14-Jan-2017

131 views 1 download

transcript

PRESCRIPTION DRUG MISUSE & ADDICTION – LEGISLATIVE TRENDSSusan AwadAmerican Society of Addiction Medicine

ABOUT ASAM

Source: Park H and Bloch M. How the Epidemic of Drug Overdose Deaths Ripples Across America. The New York Times. Jan 19, 2016. http://www.nytimes.com/interactive/2016/01/07/us/drug-overdose-deaths-in-the-us.html Accessed October 3, 2016.

POLICY TRENDS FEDERAL STATETREATMENT

Medication-Assisted Treatment (MAT)

• Increase patient limit• CARA Sec. 303• Funding

• Clinic regulations• Diversion control

Naloxone • Co-prescribing & standing orders

• Pricing

• Access laws • Good Samaritan

lawsParity • WH Task Force

• New legislation• Implementation &

enforcement

PREVENTION

PDMPs • NASPER reauthorization

• Expanded access• Mandatory

enrollment/ usePrescriber Education

• ER/LA REMS update• CDC Guideline

• Mandatory CME

Quantity Limits • Partial fills• Medicare lock-in

• Partial fills• Prescribing limits

Comprehensive Addiction and Recovery Act (CARA) Expands DATA 2000 prescribing privileges to NPs and PAs Requires updates to 8-hour course and TIP 40 Allows states to add training requirements and lower patient

limit

Administrative rule increases patient limit to 275 Qualify via board certification or practice setting Annual reporting requirements & 3-year renewal

Grants to fund treatment

Medication-Assisted Treatment

Federal

Medication-Assisted Treatment

States

CARA Sec. 107: Grants to FQHCs, OTPs, DATA 2000-waived practitioners

to support naloxone co-prescribing to patient or caregiver ($5m through 2021)

Sec. 110: Grants to states to implement standing orders & encourage pharmacies to dispense naloxone, develop training materials & education public ($5m through 2019)

House Judiciary Committee Hearing: Treating the Opioid Epidemic: The State of Competition in the Markets for Addiction Medicine (Sept. 2016)

FDA Advisory Committee (Oct. 2016)

NaloxoneFederal

NaloxoneStates

Source: National Conference of State Legislatures. Drug Overdose Immunity and Good Samaritan Laws. August 1, 2016. http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx Accessed October 3, 2016.

Naloxone Access laws may give immunity to prescribers, dispensers and/or lay administrators acting in good faith; allow for layperson distribution and possession w/o Rx; and/or allow for third-party prescribing or standing orders.

Good Samaritan laws may give immunity for bystanders from possession of a controlled substance and/or drug paraphernalia, as well as other offenses such as probation or parole violations.

Mental Health Parity and Addiction Equity Act (2008)

White House Task Force Recommendations due Oct. 31

Legislation Mental Health Reform (H.R. 2646/S. 2680) Behavioral Health Transparency Act (H.R. 4276/S. 2647)

ParityFederal

ParityStates

Source: ParityTrack. Parity Implementation National Survey. Available at: https://www.paritytrack.org/reports Accessed: October 18, 2016.

CARA Sec. 109: NASPER Reauthorization allows funds to be

used to maintain existing PDMP, improve integration with prescriber workflow; requires plan for achieving interoperability with HIT systems, facilitation of prescriber use ($10m/year through 2021)

PDMPsFederal

PDMPsStates

CDC Guideline

Surgeon General “Turn the Tide” Campaign & Report

FDA Opioids Action Plan • “Black Box” warning on opioids,

benzodiazepines• ER/LA REMS Update• CARA Sec. 106: Requires HHS Secretary to

develop recommendations regarding prescriber education on opioids

VA/DOD Guideline update

Prescriber EducationFederal

Prescriber EducationStates

Source: Federation of State Medical Boards. Continuing Medical Education Board-by-Board Overview. Available at: https://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/GRPOL_CME_Overview_by_State.pdf

State

Details

CA 12 hrs before second license renewal or w/in 4 years

FL Pain mgmt. clinics onlyIA 2 hrs every 5 years

(primary care only)KY 4.5 hrs every 3 years on

PDMP, pain mgmt. or addiction

MD 1 hr on opioid prescribingMA 3 hrs every 2 yearsNC 1 hrNH 3 hrs for initial licensure +

every 2 years

State

Details

NV 2 hrs every other 2 yr cycle

NM 5 hrs every 3 yearsOH Pain mgmt. clinics onlyOK 1 hr every 2 yearsRI 2 hrs – topic optionalSC 2 hrs every 2 yearsTN 1 hr every 2 yearsTX Pain mgmt. clinics onlyVT 1 hr on pain mgmt. + 1 hr

on controlled substances prescribing

WV 3 hrs every 3 years

CARA Sec. 702: Partial Fills of Schedule II Controlled

Substances. Allows for partial fills if requested by patient or prescriber. Remaining portions can be filled within 30 days.

Sec. 704: Medicare Part D Drug Management Program. Allows Prescription Drug Plans (PDPs) to establish patient review and restriction programs (“lock-in” programs) for beneficiaries considered at risk of prescription drug misuse.

Quantity LimitsFederal

Quantity LimitsStates

Source: K.Murphy, M.Becker, J.Locke, C.Kelleher, J.McLeod, and F.Isasi, Finding Solutions to the Prescription Opioid and Heroin Crisis: A Road Map for States (Washington, D.C.: National Governors Association Center for Best Practices, July 2016).

State Type Prescription LimitsConnecticut Statute 7-day limit for new opioid prescriptions for

adults and all opioid prescriptions for minors. Exceptions for chronic and cancer pain, palliative care and clinical judgment.

Illinois Statute Schedule II prescriptions limited to 30-day supply, with exceptions. Permits multiple prescriptions up to a 90-day supply if the prescriber meets specified conditions.

Kentucky Board rules required by statute

48-hour limit on dispensing of Schedule II and III controlled substances by physicians. No limit on opioid prescriptions.

Massachusetts

Statute 7-day limit for new opioid prescriptions for adults and all opioid prescriptions for minors. Exceptions for chronic and cancer pain, palliative care and clinical judgment.

Washington Guideline and board rules required by statute

Pain specialist consultation required prior to prescribing daily morphine equivalent doses of 120 mg or greater, with exceptions.

Susan Awad301-547-4103

sawad@asam.org

THANK YOU!